J Korean Ophthalmol Soc.  2002 Jan;43(1):11-16.

Clinical Evaluation of Recurrence Rate of Pterygium Operation according to Mitomycin C Concentration

Affiliations
  • 1Department of Ophthalmology, Kim'sEye Hospital, Seoul, Korea. phaco@unitel.co.kr

Abstract

PURPOSE: The authors compared the recurrence rate and complications of primary pterygium operation with respect to mitomycin C concentration.
METHODS
Four hundred twenty three eyes with primary pterygium underwent surgery using the bared sclera method. One hundred nineteen eyes randomly chosen were treated with 0.02% mitomycin C (Group I) twice a day for 5days, 138 eyes were treated with 0.01% mitomycin C (Group II), and 166 eyes were treated with 0.005% mitomycin C (Group III).
RESULTS
During the mean follow-up period of 6 months, the overall recurrence rate was 14.7% (62 eyes). Recurrence rates in each group : 8.4% (10 eyes) in Group I , 13.7% (19 eyes) in Group II , and 19.9% (33eyes) in Group III . Complications seen in Group I were corneal abrasion (1 eye), symblepharon (1 eye), and postoperative corneal scar (1 eye). Complications seen in Group II were symblepharon (1 eye), and postoperative corneal opacity (2 eye) and seen in Group III were symblepharon (1 eye), and postoperative corneal opacity (1 eye). We conclude that a higher concentration of mitomycin C (0.2 mg/ml) reduces the recurrence rate of pterygium.
CONCLUSIONS
We recommend the use of mitomycin C concentration of 0.02% twice a day for 5days to lower the recurrence rate and complications after excision of primary pterygium

Keyword

Mitomycin C; Primary pterygium; Recurrence rate

MeSH Terms

Cicatrix
Corneal Opacity
Follow-Up Studies
Mitomycin*
Pterygium*
Recurrence*
Sclera
Mitomycin
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr